Takeshi Kimura
Amgen Inc.
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Cardiac Valve Diseases and Treatments
Strong evidence · 5 supporting papers · latest 2026
Antiplatelet Therapy and Cardiovascular Diseases
Strong evidence · 3 supporting papers · latest 2026
Atrial Fibrillation Management and Outcomes
Strong evidence · 7 supporting papers · latest 2026
Venous Thromboembolism Diagnosis and Management
Strong evidence · 3 supporting papers · latest 2026
Cardiac, Anesthesia and Surgical Outcomes
Solid evidence · 2 supporting papers · latest 2025
Cardiac Imaging and Diagnostics
Solid evidence · 3 supporting papers · latest 2025
Psoriasis: Treatment and Pathogenesis
Solid evidence · 2 supporting papers · latest 2025
Heart Failure Treatment and Management
Solid evidence · 1 supporting paper · latest 2025
Publications (14)
TCT-847 Redefining Normal: Prognostic Implications of Left Ventricular Ejection Fraction <60% in Severe Aortic Stenosis: Insights from the CURRENT AS Registry-2
2025DOI
Stable, Progressive, and Acute Valve Syndrome in Severe Aortic Stenosis: Insights from the CURRENT AS Registry‐2.
2026DOIPMID 42348862
Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials
2026DOIPMID 41697985
Stopping Oral Anticoagulation After Catheter Ablation for Atrial Fibrillation in Patients With High Risk of Stroke: STOP‐OAC Study
2026DOIPMID 42535555
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2
2025DOIPMID 41338278
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
2025DOIPMID 41211721
Sex differences in clinical characteristics, management, and outcomes in patients with venous thromboembolism in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2
2025DOI
Prognostic Implications of Left Ventricular Ejection Fraction Across the Flow‐Gradient Patterns in Severe Aortic Stenosis
2026DOIPMID 42786617
Low-flow and normal-flow low-gradient aortic stenosis with reduced left ventricular ejection fraction. Insights from the CURRENT AS Registry-2
2025DOIPMID 41408028
Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting
2025DOIPMID 41242757
Association of Dementia With the Outcome of Patients With Heart Failure: Evidence From the Japanese KCHF Registry
2025DOIPMID 41334761
Abstract 4358890: Left Ventricular Ejection Fraction as a Prognostic Marker Across Gradient and Flow Subtypes in patients with severe aortic stenosis undergoing SAVR or TAVR: Insights from CURRENT AS Registry 2
2025DOI
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial
2025DOIPMID 41387650
Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial
2025DOIPMID 41297955
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Amgen Inc.
Source: OpenAlex · retrieved 2026-09-29